73362-102 : Palopegteriparatide 420 ug/1.4ml Subcutaneous Injection, Solution
| NDC: | 73362-102 |
| Labeler: | Ascendis Pharma, Endocrinology, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Palopegteriparatide |
| Dosage Form: | Subcutaneous Injection, Solution |
| Application #: | NDA216490 |
| Rev. Date: |
NDC Package Codes:
- 73362-102-01: 2 BOX IN 1 CARTON (73362‑102‑01) / 1 SYRINGE IN 1 BOX (73362‑102‑02) / 1 CONTAINER IN 1 SYRINGE (73362‑102‑03) / 1.4 ML IN 1 CONTAINER
Active Ingredients:
- Palopegteriparatide
Dosage Strength:
- 420 ug/1.4mL
Pharmaceutical Classes:
- Parathyroid Hormone Analog [EPC]
- Parathyroid Hormone [CS]
Related Products:
Based on records with the same trade name.- 73362-100 Palopegteriparatide 168 ug/.56ml Subcutaneous Injection, Solution by Ascendis Pharma, Endocrinology, Inc.
- 73362-101 Palopegteriparatide 294 ug/.98ml Subcutaneous Injection, Solution by Ascendis Pharma, Endocrinology, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 73362-101Next: 73364-1111 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.